Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Share-based Compensation (IS) (2016 - 2025)

Avricore Health has reported Share-based Compensation (IS) over the past 11 years, most recently at $27935.5 for Q4 2025.

  • Quarterly Share-based Compensation (IS) fell 77.57% to $27935.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $201107.5 through Dec 2025, down 48.95% year-over-year, with the annual reading at $200886.5 for FY2025, 49.18% down from the prior year.
  • Share-based Compensation (IS) was $27935.5 for Q4 2025 at Avricore Health, down from $37426.1 in the prior quarter.
  • Over five years, Share-based Compensation (IS) peaked at $305717.0 in Q1 2021 and troughed at $1168.4 in Q2 2024.
  • The 5-year median for Share-based Compensation (IS) is $52051.3 (2021), against an average of $87883.8.
  • Year-over-year, Share-based Compensation (IS) tumbled 99.07% in 2024 and then skyrocketed 7828.53% in 2025.
  • A 5-year view of Share-based Compensation (IS) shows it stood at $7274.1 in 2021, then skyrocketed by 2361.04% to $179018.8 in 2022, then crashed by 41.42% to $104866.0 in 2023, then rose by 18.79% to $124567.1 in 2024, then tumbled by 77.57% to $27935.5 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Share-based Compensation (IS) are $27935.5 (Q4 2025), $37426.1 (Q3 2025), and $92634.0 (Q2 2025).